In the last few decades, numerous molecular markers have been exploited to detect CRC and predict outcomes, such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) [3–6]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.